Oncocyte Corporation Appoints Andrea James as Chief Financial Officer and Principal Financial Officer
Position
Chief Financial Officer
Company
Insight Molecular Diagnostics Inc.
IrvineBiotechnologyHealth CareGeneticsHealth DiagnosticsDescription
Oncocyte Corporation has appointed Andrea James as their new Chief Financial Officer and Principal Financial Officer, effective June 17, 2024. Ms. James brings a wealth of experience to the role, with a rich background in investor relations and corporate strategy.
Quick answer
Oncocyte Corporation Appoints Andrea James as Chief Financial Officer and Principal Financial Officer (June 17, 2024). Insight Molecular Diagnostics Inc. is based in Irvine, California, United States.
- Who is the new Chief Financial Officer at Insight Molecular Diagnostics Inc?
- Insight Molecular Diagnostics Inc. named Andrea James Chief Financial Officer, announced June 17, 2024.
- What did Insight Molecular Diagnostics Inc. announce on June 17, 2024?
- Oncocyte Corporation has appointed Andrea James as their new Chief Financial Officer and Principal Financial Officer, effective June 17, 2024. Ms. James brings a wealth of experience to the role, with a rich background in investor relations and corporate strategy.
- What does Insight Molecular Diagnostics Inc. do?
- Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
- Where is Insight Molecular Diagnostics Inc. based?
- Insight Molecular Diagnostics Inc. is based in Irvine, California, United States.
- Which similar companies made leadership changes around the same time?
- Genetic Technologies Limited (July 16, 2024), Progentec Diagnostics (June 17, 2024), Wren Laboratories (June 17, 2024) and Element Biosciences (June 26, 2024) also announced leadership changes within 45 days of Insight Molecular Diagnostics Inc.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Health Diagnostics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Genetic Technologies Appoints Mark Ziirsen as Chief Financial Officer & Company Secretary (July 16, 2024)
- Progentec Diagnostics Appoints Bernard R. Rubin, DO, MPH (FACR, FACP) as Chief Medical Officer (June 17, 2024)
- Wren Laboratories Appoints Dr. Abdel Halim as Chief Executive Officer and Chief Scientific Officer, Troy Tremaine as Senior Vice President and Chief Commercial Officer (June 17, 2024)
- Element Biosciences Appoints Amirali Kia, PhD as Vice President of Artificial Intelligence and Tina Tian, PhD as Vice President of Portfolio Management (June 26, 2024)
- Blackford Welcomes Chris Meenan as Chief Product Officer (June 27, 2024)
- Mosaic Diagnostics Appoints Rob Rebak as Chief Executive Officer (June 27, 2024)
Who to call at Insight Molecular Diagnostics Inc., and when
A new leader at Insight Molecular Diagnostics Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Insight Molecular Diagnostics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Insight Molecular Diagnostics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Insight Molecular Diagnostics Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Insight Molecular Diagnostics Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Insight Molecular Diagnostics Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.